A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
Kohei Murakami(Shinshu University), Yukio Nakamura(Shinshu University)
Cited by 93
Related Papers
The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling
|Journal of Clinical Investigation|2007|92